Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway
Jie Zhao, Ann L. Wozniak, Abby Adams, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 81

Showing 26-50 of 81 citing articles:

Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy
Lianhui Sun, Xinyang Xu, Zhuqing Zhang, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115269-115269
Open Access
SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner
Zhiyi Hu, Ming Tang, Yujia Huang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
SIRT7-mediated NRF2 deacetylation promotes antioxidant response and protects against chemodrug-induced liver injury
Tingzi Yu, Cong Ding, Jinying Peng, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Targeting Nuclear NAD+ Synthesis Inhibits DNA Repair, Impairs Metabolic Adaptation and Increases Chemosensitivity of U-2OS Osteosarcoma Cells
Alexandra Kiss, Arnold Péter Ráduly, Zsolt Regdon, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1180-1180
Open Access | Times Cited: 30
DDX3X interacts with SIRT7 to promote PD-L1 expression to facilitate PDAC progression
Tianming Zhao, Hanlong Zhu, Tianhui Zou, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
NAD metabolism in aging and cancer
John W. R. Kincaid, Nathan A. Berger
Experimental Biology and Medicine (2020) Vol. 245, Iss. 17, pp. 1594-1614
Open Access | Times Cited: 24
CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma
Chen Zhang, Jinqiu Zhao, Jie Zhao, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 12, pp. 1961-1974
Open Access | Times Cited: 15
The dark side of SIRT7
Francisco Alejandro Lagunas‐Rangel
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 11, pp. 2843-2861
Closed Access | Times Cited: 8
ZNF143 Suppresses Cell Apoptosis and Promotes Proliferation in Gastric Cancer via ROS/p53 Axis
Yi Zhang, Qing Li, Wei Song, et al.
Disease Markers (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 21
SIRT7 Acts as a Guardian of Cellular Integrity by Controlling Nucleolar and Extra-Nucleolar Functions
Poonam Kumari, Shahriar Tarighi, Thomas Braun, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1361-1361
Open Access | Times Cited: 20
Biochemical Mechanisms of Sirtuin-Directed Protein Acylation in Hepatic Pathologies of Mitochondrial Dysfunction
Courtney D. McGinnis, Erin Q. Jennings, Peter S. Harris, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2045-2045
Open Access | Times Cited: 12
Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives
María Paula Ceballos, Ariel D. Quiroga, Nicolás Francisco Palma
Biochemical Pharmacology (2023) Vol. 212, pp. 115573-115573
Closed Access | Times Cited: 6
Sirt6 Deacetylase: A Potential Key Regulator in the Prevention of Obesity, Diabetes and Neurodegenerative Disease
Swapnil Raj, Liston Augustine Dsouza, Shailendra Pratap Singh, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 18
Potent Activation of NAD+-Dependent Deacetylase Sirt7 by Nucleosome Binding
Vyacheslav I. Kuznetsov, Wallace H. Liu, Mark A. Klein, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 8, pp. 2248-2261
Open Access | Times Cited: 10
Sorafenib/2800Z Co-Loaded into Cholesterol and PEG Grafted Polylysine NPs for Liver Cancer Treatment
Chen Zhang, Wu Zhong, Ying Cao, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 119-119
Open Access | Times Cited: 6
Emerging role and therapeutic implications of p53 in intervertebral disc degeneration
Yidian Wang, Shou‐Ye Hu, Weisong Zhang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Deacetylation of Transcription Factors in Carcinogenesis
Marta Hałasa, Kamila Adamczuk, Grzegorz Adamczuk, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11810-11810
Open Access | Times Cited: 13
Bioinformatic Analysis of the Effect of the Sirtuin Family on Differentiated Thyroid Carcinoma
Yao Li-jun, Yinhua Wang
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 9
Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation
Xiaomeng Jia, Huijiao Liu, Xinmin Ren, et al.
Oncogene (2022) Vol. 41, Iss. 39, pp. 4474-4484
Closed Access | Times Cited: 9
Molecular docking‐based virtual screening and dynamics simulation study of novel and potential SIRT7 inhibitors
Xinli Guo, Rui Chen, Liping Cao
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 4, pp. 707-717
Closed Access | Times Cited: 5
Role of sirtuins in liver diseases
Devaraj Ezhilarasan, Mustapha Najimi
Elsevier eBooks (2021), pp. 329-340
Closed Access | Times Cited: 12
Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting SIRT7 expression
Minhua Wu, Su‐Chun Hui, Yong‐Syuan Chen, et al.
Environmental Toxicology (2021) Vol. 36, Iss. 11, pp. 2206-2216
Closed Access | Times Cited: 12
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
José J.G. Marı́n, Marta R. Romero, Elisa Herráez, et al.
Seminars in Liver Disease (2021) Vol. 42, Iss. 01, pp. 087-103
Closed Access | Times Cited: 12
Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature
Peng Huang, Bin Zhang, Junsheng Zhao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 8
Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma
Masae Yanai, Morito Kurata, Yutaka Muto, et al.
Pathology (2020) Vol. 52, Iss. 5, pp. 529-537
Closed Access | Times Cited: 12

Scroll to top